No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

No description, website, or topics provided.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

By activating a master epigenetic switch using CRISPR, naturally suppressed genes can be turned on, offering hope for ...

Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...